Form 8-K

8-K — Healthcare Triangle, Inc.

Accession: 0001213900-26-103604

Filed: 2026-09-25

Period: 2026-09-22

CIK: 0001839285

SIC: 7373 (SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN)

Item: Entry into a Material Definitive Agreement

Item: Financial Statements and Exhibits

Documents

8-K — ea0306547-8k_healthcare.htm (Primary)

EX-10.1 — FIRST AMENDMENT TO THE EQUITY PURCHASE AGREEMENT DATED SEPTEMBER 22, 2026, BY AND BETWEEN HEALTHCARE TRIANGLE, INC. AND HUDSON GLOBAL VENTURES, LLC (ea030654701ex10-1.htm)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K — CURRENT REPORT

8-K (Primary)

Filename: ea0306547-8k_healthcare.htm · Sequence: 1

false

0001839285

2026-09-22

iso4217:USD

xbrli:shares

iso4217:USD

xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported):

September 22, 2026

HEALTHCARE TRIANGLE, INC.

(Exact name of registrant as specified in its charter)

Delaware

001-40903

84-3559776

(State or other jurisdiction

of incorporation)

(Commission File Number)

(I.R.S. Employer

Identification No.)

7901 Stoneridge Drive, Suite 210

Pleasanton, California 94588

(Address of principal executive offices, including

zip code)

(925)-270-4812

(Registrant’s telephone number, including

area code)

N/A

(Former name or former address, if changed since

last report)

Check the appropriate box below if the Form 8-K

filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b)

of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, par value $0.00001 per share

HCTI

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant

is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the

Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check

mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting

standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 1.01 Entry into a Material Definitive Agreement.

On September 22, 2026, Healthcare Triangle, Inc.

(“HCTI” or the “Company”), a Delaware corporation, entered into the First Amendment to the Equity Purchase Agreement

(the “Amendment”), which amends the Equity Purchase Agreement dated as of June 12, 2026 (the “Equity Purchase Agreement”)

with Hudson Global Ventures, LLC, a Nevada limited liability company (the “Investor”). The Equity Purchase Agreement was filed as exhibit 10.2 to the Current Report on Form 8-K filed on June 15, 2026.

Pursuant to the Amendment, certain terms of the

Equity Purchase Agreement are modified as follows:

● Purchase Price. The Amendment redefines “Purchase Price” to mean the Initial Purchase Price (as defined in the Equity Purchase Agreement), calculated on the applicable date in accordance with the terms and conditions of the Equity Purchase Agreement.

●

Valuation Period. The Amendment redefines “Valuation Period” to mean the applicable Put Date (as defined in

the Equity Purchase Agreement).

●

Maximum Put Amount. The Amendment reduces the maximum amount that may be sold pursuant to each Put Notice (as defined in

the Equity Purchase Agreement) under Section 2.1 of the Equity Purchase Agreement from $2,500,000 to $250,000.

●

Minimum Price per Share. The Amendment increases the minimum price per share threshold under Section 7.1(o) of the Equity

Purchase Agreement from $0.01 per share to $0.10 per share, subject to appropriate adjustment for any stock dividend, stock split, stock

combination, rights offerings, reclassification, or similar transaction that proportionately decreases or increases the Common Stock

(as defined in the Equity Purchase Agreement).

●

Change of Control. The Amendment adds a new Change of Control provision, which provides that upon the occurrence of a Change

of Control Transaction (as defined in the Amendment), the Company shall no longer have the right to deliver any Put Notice to the Investor.

Except as expressly amended by the Amendment,

all other terms and conditions of the Equity Purchase Agreement remain in full force and effect.

The foregoing descriptions of the Amendment do

not purport to be complete and are qualified in their entirety by reference to the full text of the Amendment, a copy of which is filed

as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.

Description

10.1

First Amendment to the Equity Purchase Agreement dated September 22, 2026, by and between Healthcare Triangle, Inc. and Hudson Global Ventures, LLC

104

Cover Page Interactive Data File (embedded within the Inline XBRL document)

Forward-Looking Statements

Certain statements made in this Current Report

on Form 8-K are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended,

Section 21E of the Securities Exchange Act of 1934, as amended, and the “safe harbor” provisions under the Private Securities

Litigation Reform Act of 1995. All statements other than statements of historical fact included in this Current Report on Form 8-K are

forward-looking statements. When used in this Current Report on Form 8-K, words such as “anticipate,” “believe,”

“continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,”

“plan,” “possible,” “potential,” “predict,” “project,” “should,”

“would” and variations of these words or similar expressions (or the negative versions of such words or expressions), as they

relate to the Company or its management team, are intended to identify forward-looking statements. Forward-looking statements are not

guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and

other important factors, many of which are beyond the control of the Company, including those set forth in the “Risk Factors”

section of the Company’s Annual Report on Form 10-K filed on April 15, 2026, as amended, and other reports and registration statements

of the Company filed, or to be filed, with the Securities and Exchange Commission, that could cause actual results or outcomes to differ

materially from those discussed in the forward-looking statements. All subsequent written or oral forward-looking statements attributable

to the Company or persons acting on its behalf are qualified in their entirety by this paragraph. The Company undertakes no obligation

to update or revise any forward-looking statements for revisions or changes after the date of this Current Report on Form 8-K, except

as required by law.

SIGNATURES

Pursuant to the requirements of the Securities

Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: September 25, 2026

Healthcare Triangle, Inc.

By:

/s/ David Ayanoglou

Name:

David Ayanoglou

Title:

Chief Financial Officer

EX-10.1 — FIRST AMENDMENT TO THE EQUITY PURCHASE AGREEMENT DATED SEPTEMBER 22, 2026, BY AND BETWEEN HEALTHCARE TRIANGLE, INC. AND HUDSON GLOBAL VENTURES, LLC

EX-10.1

Filename: ea030654701ex10-1.htm · Sequence: 2

Exhibit 10.1

FIRST AMENDMENT TO THE

EQUITY PURCHASE AGREEMENT

This first amendment

(this “Amendment”) to the Agreement (as defined below) is entered into as of September 22, 2026 (the “Effective Date”),

by and between Healthcare Triangle, Inc., a Delaware corporation (the “Company”), and Hudson Global Ventures, LLC, a Nevada

limited liability company (the “Investor”, and collectively with the Company, the “Parties”).

WHEREAS the

Parties entered into an equity purchase agreement on or around June 12, 2026 (the “Agreement”); and

WHEREAS,

the Parties now desire to amend the Agreement;

NOW, THEREFORE,

the Parties hereto agree as follows:

1. Purchase Price. Notwithstanding anything to the contrary

in the Agreement, “Purchase Price” shall mean the Initial Purchase Price, on such date on which the Purchase Price is calculated

in accordance with the terms and conditions of the Agreement.

2. Valuation Period. Notwithstanding anything to the contrary

in the Agreement, “Valuation Period” shall mean the applicable Put Date.

3. Section 2.1 Amendment. The reference to “$2,500,000.00”

in Section 2.1 of the Agreement shall be replaced with “$250,000.00”.

4. Section 7.1(o) Amendment. The reference to “$0.01

per share” in Section 7.1(o) of the Agreement shall be replaced with “$0.10 per share, subject to appropriate adjustment

for any stock dividend, stock split, stock combination, rights offerings, reclassification or similar transaction that proportionately

decreases or increases the Common Stock”.

5. Change of Control. If a Change of Control Transaction

(as defined in this Amendment) occurs at any time on or after the Effective Date, then the Company shall no longer have the right to

deliver any Put Notice (as defined in the Agreement) under the Agreement to Investor at any time on or after the occurrence of the Change

of Control Transaction. “Change of Control Transaction” means any of (a) an acquisition after the date hereof by an individual

or legal entity or “group” (as described in Rule 13d-5(b)(1) promulgated under the Securities Exchange Act of 1934, as amended)

of effective control (whether through legal or beneficial ownership of capital stock of the Company, by contract or otherwise) of in

excess of 50% of the voting securities of the Company, (b) the Company merges into or consolidates with any other Person (as defined

in the Agreement) (each a “Person”), or any Person merges into or consolidates with the Company and, after giving effect

to such transaction, the stockholders of the Company immediately prior to such transaction own less than 66% of the aggregate voting

power of the Company or the successor entity of such transaction, (c) the Company sells or transfers all or substantially all of its

assets to another Person and the stockholders of the Company immediately prior to such transaction own less than 66% of the aggregate

voting power of the acquiring entity immediately after the transaction, (d) a replacement at one time or within a three year period of

more than one-half of the members of the Board of Directors who are members on the Effective Date, or (e) the execution by the Company

of an agreement to which the Company is a party or by which it is bound, providing for any of the events set forth in clauses (a) through

(d) above.

6. Governing Law; Venue. Section 10.1 of the Agreement

shall apply to this Amendment.

7. Effect of Amendment; Full Force and Effect. This Amendment

shall form a part of the Agreement for all purposes, and each of the Parties shall be bound hereby and this Amendment and the Agreement

shall be read and interpreted as one combined instrument. From and after the date hereof, each reference in the Agreement to “this

Agreement,” “hereof,” “hereunder,” “herein,” “hereby” or words of like import referring

to the Agreement shall mean and be a reference to the Agreement as amended by this Amendment. Except as herein expressly amended or otherwise

provided herein, each and every term, condition, warranty and provision of the Agreement shall remain in full force and effect, and such

are hereby ratified, confirmed and approved by the Parties.

8. Counterparts. This Amendment may be executed in one

or more counterparts, each of which shall be deemed to be an original, but all of which shall constitute one and the same agreement.

Delivery of an executed counterpart of a signature page to this Amendment by electronic means, including DocuSign, Adobe Sign or other

similar e-signature services, e-mail or scanned pages shall be effective as delivery of a manually executed counterpart to this Amendment.

[Signature Page Follows]

WITNESS WHEREOF, the Parties have caused this Amendment to be duly executed by their respective officers thereunto duly authorized

as of the Effective Date.

COMPANY:

HEALTHCARE TRIANGLE, INC.

By:

/s/ David Ayanoglou

Name:

David Ayanoglou

Title:

Chief Financial Officer

INVESTOR:

HUDSON GLOBAL VENTURES, LLC

By:

/s/ Seth Ahdoot

Name:

Seth Ahdoot

Title:

Member

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 7

v3.26.3

Cover

Sep. 22, 2026

Cover [Abstract]

Document Type

8-K

Amendment Flag

false

Document Period End Date

Sep. 22, 2026

Entity File Number

001-40903

Entity Registrant Name

HEALTHCARE TRIANGLE, INC.

Entity Central Index Key

0001839285

Entity Tax Identification Number

84-3559776

Entity Incorporation, State or Country Code

Entity Address, Address Line One

7901 Stoneridge Drive

Entity Address, Address Line Two

Suite 210

Entity Address, City or Town

Pleasanton

Entity Address, State or Province

Entity Address, Postal Zip Code

94588

City Area Code

(925)

Local Phone Number

270-4812

Written Communications

false

Soliciting Material

false

Pre-commencement Tender Offer

false

Pre-commencement Issuer Tender Offer

false

Title of 12(b) Security

Common Stock, par value $0.00001 per share

Trading Symbol

HCTI

Security Exchange Name

NASDAQ

Entity Emerging Growth Company

true

Elected Not To Use the Extended Transition Period

false

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Cover page.

+ References

No definition available.

+ Details

Name:

dei_CoverAbstract

Namespace Prefix:

dei_

Data Type:

xbrli:stringItemType

Balance Type:

Period Type:

duration

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

Period Type:

duration

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 2 such as Street or Suite number

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine2

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the state or province.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressStateOrProvince

Namespace Prefix:

dei_

Data Type:

dei:stateOrProvinceItemType

Balance Type:

Period Type:

duration

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 7A

-Section B

-Subsection 2

+ Details

Name:

dei_EntityExTransitionPeriod

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

Period Type:

duration

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

Period Type:

duration

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

Period Type:

duration

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Title of a 12(b) registered security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b

+ Details

Name:

dei_Security12bTitle

Namespace Prefix:

dei_

Data Type:

dei:securityTitleItemType

Balance Type:

Period Type:

duration

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection d1-1

+ Details

Name:

dei_SecurityExchangeName

Namespace Prefix:

dei_

Data Type:

dei:edgarExchangeCodeItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:

dei_TradingSymbol

Namespace Prefix:

dei_

Data Type:

dei:tradingSymbolItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration